Try our Advanced Search for more refined results

October 24, 2014

Andavarapu v. iBio Inc. et al

Track this case

Case Number:

1:14-cv-01343

Court:

Delaware

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Richard G. Andrews

Firms

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 21, 2016

    IBio Settles Investor Suit Over Ebola Drug Plans For $1.87M

    Pharmaceutical company iBio Inc. settled a putative securities class action in Delaware federal court Thursday, agreeing to pay roughly $1.87 million and attorneys' fees for allegedly fabricating a joint venture to manufacture an Ebola treatment in an effort to pump up the company's value at a time when the disease was ravaging Africa.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login